Taysha Gene Therapies
TSHA
#5807
Rank
$1.22 B
Marketcap
$3.77
Share price
-5.51%
Change (1 day)
-5.99%
Change (1 year)

Taysha Gene Therapies (TSHA) - Net assets

Net assets on the balance sheet as of June 2026 : $0.38 Billion USD

According to Taysha Gene Therapies's latest financial reports the company has $0.38 Billion USD in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Taysha Gene Therapies - Net assets on balance sheet (from 2020 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$$0.24 B245.25%
2024-12-31$$71.52 M-4.55%
2023-12-31$$74.93 M7796.42%
2022-12-31$$0.94 M-99.01%
2021-12-31$$95.38 M-62.04%
2020-12-31$$0.25 B-186249.63%
2019-12-31$-$0.14 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ORIC Pharmaceuticals
ORIC
$0.38 B-1.55%๐Ÿ‡บ๐Ÿ‡ธ USA